Get started
Author

V. V. Arkhipov

Observed names: V V Arkhipov, V.V. Arkhipov, Vladimir V. Arkhipov, Vladimir Vladimirovich Arkhipov, Архипов В.В.
Observed institutions: Belgorod National Research University, Sechenov University, Russian Cancer Research Center NN Blokhin, Russian Medical Academy of Continuous Professional Education, Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology, Ministry of Health of the Russian Federation, Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP), Saint Petersburg State Pediatric Medical University
ORCID: 0000-0002-1441-3418
Observed ORCID: 0000-0002-1441-3418
OpenAlex ID: A5030191237
Criteria for Assessment of Cognitive Impairment in Clinical Trials
2018 · A. P. Solovyova, D. V. Goryachev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 32
PDF
Safety of Herbal Medicines: Clinical and Pharmacological Aspects
2020 · O. A. Demidova, V. V. Arkhipov, et al. · Safety and Risk of Pharmacotherapy · 13
PDF
Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia
2020 · M.V. Zhuravleva, A.B. Prokofiev, et al. · S S Korsakov Journal of Neurology and Psychiatry · 11
Meta-analytical evaluation of the clinical efficacy of a complex metabolic neuroprotector in patients with chronic cerebral ischemia
2022 · M. V. Zhuravleva, G. I. Gorodetskay, et al. · Antibiot Khimioter = Antibiotics and Chemotherapy · 8
PDF
Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid
2023 · N. A. Shnayder, V. V. Grechkina, et al. · Safety and Risk of Pharmacotherapy · 7
PDF
Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia
2022 · M.V. Zhuravleva, P.R. Kamchatnov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 6
Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke
2020 · M.V. Zhuravleva, I.A. Shchukin, et al. · S S Korsakov Journal of Neurology and Psychiatry · 6
Correction of oxidative stress in patients with chronic cerebral ischemia
2016 · Olga A. Goroshko, K. N. Novikov, et al. · Clinical Medicine (Russian Journal) · 6
Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
2024 · N. A. Shnayder, V. V. Grechkina, et al. · Safety and Risk of Pharmacotherapy · 4
Efficacy and Safety of Antiepileptic Drugs During Pregnancy: Pharmacogenetic Aspects
2018 · E. A. Sоkоvа, V. V. Arkhipov, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 3
PDF
Off-Label Use of Neovasculgen for II–III Degree Foot Frostbite: A Case Report
2024 · R. V. Ishchenko, E. Ya. Fistal, et al. · Safety and Risk of Pharmacotherapy · 2
Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion)
2022 · M. M. Tanashyan, N. A. Shamalov, et al. · Neurology neuropsychiatry Psychosomatics · 2
PDF
Some Aspects of Drug Induced Nephrotoxicity Assessment
2020 · E. A. Sokova, V. V. Arkhipov, et al. · Safety and Risk of Pharmacotherapy · 2
PDF
Analysis of Safety Issues of Using Statins in Patients with Diabetes and Hypothyroidism
2019 · V. V. Arkhipov, G. I. Gorodetskaya, et al. · Safety and Risk of Pharmacotherapy · 2
PDF
Candidate Genes Associated with the Course of Epilepsy in Cerebral Palsy: Remission or Refractoriness
2023 · P. L. Sokolov, N. V. Chebanenko, et al. · Personalized Psychiatry and Neurology · 1
PDF
Current Approaches to Assessing the Safety and Efficacy of Lamotrigine in Children and Adolescents with Epileptic Syndromes Associated with Focal Seizures
2023 · V. V. Arkhipov, N. V. Chebanenko, et al. · Safety and Risk of Pharmacotherapy · 1
PDF
Personalized Methodological Approaches to the Issues of Monitoring the Effectiveness and Safety of Pharmacotherapy with Antiepileptic Drugs Based on Mobile Medicine Technologies
2023 · V. V. Arkhipov, K. M. Mantserov · Personalized Psychiatry and Neurology · 1
PDF
Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases
2022 · Yu. R. Bolsunovskaya, V. V. Arkhipov · Safety and Risk of Pharmacotherapy · 1
PDF
Assessment of Safety Signals for Aztreonam in Different Age Groups: National and International Drug Safety Monitoring
2022 · E. A. Sokova, V. V. Arkhipov, et al. · Safety and Risk of Pharmacotherapy · 1
PDF
Automated Information Systems as a New Approach to Risk Management of Pharmacotherapy in the Treatment of Epilepsy
2022 · V. V. Arkhipov, N. I. Burmistrova · Safety and Risk of Pharmacotherapy · 1
PDF
Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19
2022 · V. V. Arkhipov, T. S. Kheilo, et al. · Safety and Risk of Pharmacotherapy · 1
PDF
The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect
2018 · S. P. Sergeeva, А. А. Savin, et al. · Neurology neuropsychiatry Psychosomatics · 1
PDF
Prediction of the outcome of the acute phase of ischemic stroke: the role of apoptotic markers
2017 · Svetlana P. Sergeeva, A. A. Savin, et al. · Annals of Clinical and Experimental Neurology · 1
PDF
Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats
2025 · O. V. Shcheblykina, D. A. Kostina, et al. · Safety and Risk of Pharmacotherapy
Assessment of the severity of delayed changes in the state of the neuromuscular system during correction of local cold injury of III-IV degree with pCMV-VEGF165 plasmid preparation in an experiment
2025 · Darya A. Kostina, Olesya V. Shcheblykina, et al. · Research Results in Pharmacology
Works count: 39
Citation count: 114
H-index: 6
I10-index: 3
Year
Topic
Type